All AbMole products are for research use only, cannot be used for human consumption.
Valubicin is a chemotherapeutic compound for bladder cancer. Valubicin, a semi-synthetic compound similar to anthracycline doxorubicin, is injected directly into the bladder.
| Molecular Weight | 723.64 |
| Formula | C34H36F3NO13 |
| CAS Number | 56124-62-0 |
| Form | Solid |
| Solubility (25°C) | DMSO 30 mg/ml |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
[2] Pranav Sharma, et al. Valrubicin in refractory non-muscle invasive bladder cancer
[3] E Hauge, et al. Topical valrubicin application reduces skin inflammation in murine models
| Related PKC Products |
|---|
| Sapintoxin D
Sapintoxin D is a fluorescent phorbol ester that can be used to study the activation of protein kinase C (PKC). |
| Bryostatin 3
Bryostatin 3, a macrocyclic lactone, is a protein kinase C activator, with a Ki of 2.75 nM. |
| Ruboxistaurin mesylate
Ruboxistaurin (LY333531) mesylate is an orally active, selective and ATP competitive PKCβ inhibitor with IC50 values of 4.7 and 5.9 nM for PKCβI and PKCβII, respectively. |
| PKC β pseudosubstrate
PKC β pseudosubstrate is a selective cell-permeable inhibitor of PKC. |
| Protein Kinase C (19-31)
Protein Kinase C (19-31), a peptide inhibitor of protein kinase C (PKC), is used as protein kinase C substrate peptide for testing the protein kinase C activity. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
